InvestorWire NewsRoom

Press Release

Grapefruit USA, Inc. Announces NNCP Submission to Health Canada to Enable Canada-Wide Sale of Grapefruit’s Patented Hourglass™ Time Release THC+CBD Delivery Cream
January 20, 2022

Grapefruit USA, Inc. Announces NNCP Submission to Health Canada to Enable Canada-Wide Sale of Grapefruit’s Patented Hourglass™ Time Release THC+CBD Delivery Cream

LOS ANGELES and DESERT HOT SPRINGS, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, is pleased to announce that its licensed distribution partner Medz Cannabis has filed a Notice of New Cannabis Product (“NNCP”) with Health Canada on Grapefruit’s behalf. Approval of the NNCP by Health Canada will enable Grapefruit to sell its patented Hourglass™ Time Release THC+CBD-Infused Topical Delivery Cream to licensed retail outlets throughout Canada.

Health Canada is the Canadian federal government department that is responsible for national health policy. It approves and oversees the production of all cannabis products and is the licensing authority for all companies involved in the cannabis industry. Health Canada requires that all cannabis products meet federal regulatory requirements before they can be sold in Canada. Under Canada’s Federal Cannabis Regulatory scheme, Health Canada must be notified of a company’s intent to sell a cannabis product that has not previously been sold in the country. Approval of the NNCP is a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. Accordingly, Grapefruit’s NNCP has been submitted to Health Canada in anticipation of its approval and Grapefruit’s subsequent sales launch of Hourglass technology-based THC and CBD products in Canada in 2022.

Grapefruit believes its Hourglass™ THC/CBD delivery cream system is a truly disruptive technology that has fundamentally changed the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without the dangers of smoking and oral ingestion. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids. The disruptive Hourglass delivery system enables humans, for the first time, to effectively use a variety of cannabis products in a healthy fashion. Simply put, Hourglass works without the associated health risks from smoking or orally ingesting THC and CBD.

Bradley J. Yourist, Grapefruit’s CEO and co-founder, commented, “We are pleased to launch our Canadian Hourglass initiative. We are confident that Canadians who wish to enjoy the holistic benefits of THC/CBD and other cannabinoids without smoking or eating them will embrace Hourglass THC/CBD/cannabinoid cream.”

For additional information about Hourglass Canada, please visit:

To purchase Grapefruit’s groundbreaking CBD delivery relief cream outside of Canada, please visit:

To learn more about Grapefruit’s new sustained-release Hourglass™ THC+Cannabinoid Topical Delivery Cream, please watch this promotional video:
and visit our website at:

For investor information, please visit our website at:

Follow us on Facebook, Instagram, LinkedIn and Twitter:
Facebook | Instagram | LinkedIn | Twitter

About Grapefruit

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. To obtain further information on Grapefruit and its operations, please visit the Company’s website at

Safe Harbor Statement

Grapefruit cautions that any statement included in this press release that is not a description of historical facts is a forward-looking statement. Many of these forward-looking statements contain the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties inherent in Grapefruit’s business, including, without limitation: the Company may not ever obtain additional funds necessary to support its business development and growth plans; and the Company may not ever achieve the market success to reach or sustain a profitable business. In addition, there are risks and uncertainties related to economic recession or terrorist actions, competition from much larger cannabis companies, unexpected costs and delays, potential product liability claims and many other factors. More detailed information about Grapefruit and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, its Quarterly Report on Form 10-Q for the period ended Sept. 30, 2021, and its Registration Statement on Form S-1/A. Such documents may be read free of charge on the SEC’s website at Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Grapefruit undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Investor Relations Contact:
Bradley Yourist
[email protected]
18776 Blue Dream Crossing, Unit LL1 53-07
Desert Hot Springs, California 92240
(760) 205-1382

Please be aware that our social media accounts can be used from time to time for additional material events. They can be found here:

Grapefruit USA:

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
310.299.1717 Office
[email protected]

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).